==== Front Indian J OphthalmolIndian J OphthalmolIJOIndian Journal of Ophthalmology0301-47381998-3689Medknow Publications & Media Pvt Ltd India 30038184IJO-66-120510.4103/ijo.IJO_142_18Case ReportsToxoplasma retinitis following intravitreal injection of triamcinolone acetonide: A case report and review of literature Ahmed Arshee Sudharshan Sridharan Gopal Sriram 1Majumder Parthopratim Dutta Biswas Jyotirmay Department of Uvea, Sankara Nethralaya, Chennai, Tamil Nadu, India1 Athreya Retinal Centre, Trichy, Tamil Nadu, India Correspondence to: Dr. Sridharan Sudharshan, Sankara Nethralaya, College Road, Nungambakkam, Chennai - 600 006, Tamil Nadu, India. E-mail: drdharshan@gmail.com8 2018 66 8 1205 1208 28 1 2018 24 4 2018 Copyright: © 2018 Indian Journal of Ophthalmology2018This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.The aim of this study was to report a case of atypical toxoplasma retinochoroiditis following intravitreal triamcinolone acetonide (IVTA) injection and to review the literature pertaining to toxoplasma retinochoroiditis following intravitreal injection of corticosteroid. Clinical data were collected from a 64-year-old male who developed toxoplasma retinitis 2 months after IVTA. A review of the literature was conducted to identify additional reports on similar cases. A 64-year-old male, known diabetic with nonproliferative diabetic retinopathy in both the eyes and optic atrophy in the left eye, presented with atypical retinitis inferior to the disc following IVTA. Real-time polymerase chain reaction and serology confirmed the toxoplasma etiology, and the patient was started on anti-toxoplasma therapy along with oral corticosteroid leading to regression of the lesion by 3 months. A high index of suspicion and proper microbiological diagnosis with appropriate antimicrobial therapy can aid in the management of toxoplasma retinochoroiditis following intravitreal injection of corticosteroid. Diabetestoxoplasmosistriamcinolone ==== Body Intravitreal corticosteroids have been in use for various conditions such as diabetic macular edema, vein occlusions, pseudophakic cystoid macular edema, and a variety of uveitic diseases. Common adverse events include cataract formation and steroid-induced glaucoma, endophthalmitis, vitreous hemorrhage, and retinal detachment. There have been reports of infective uveitis following injection of intravitreal corticosteroids in recent years.[1234] Although majority of them reported a viral etiology,[14567] rare presentations of acute syphilitic posterior placoid chorioretinitis[28] and toxoplasma retinochoroiditis[39] following intravitreal injection of corticosteroid have been reported. Typical toxoplasma lesions include unilateral focal retinochoroiditis at the border of a preexisting pigmented retinochoroidal lesion and overlying vitritis. However, atypical lesions may consist of large areas of retinal necrosis or retinochoroiditis without adjacent preexisting pigmented retinal scar or retinochoroiditis in both the eyes. Such atypical lesions are seen in elderly individuals and in those with underlying immunodeficiency due to various causes.[10] We report an unusual case of an atypical toxoplasma retinochoroiditis after intravitreal triamcinolone acetonide (IVTA) injection in an elderly diabetic patient. A detailed review of the literature on PubMed was conducted using such terms as intravitreal, corticosteroid, toxoplasma retinochoroiditis, and ocular toxoplasmosis. Additional studies were also looked for from the bibliographies of the retrieved articles. Case Report A 64-year-old male presented to our uveitis clinic with complaints of blurring of vision in the right eye of 10-day duration. He was a known diabetic for 14 years and documented to have nonproliferative diabetic retinopathy in both the eyes and optic atrophy (due to probable ischemic optic neuropathy) in the left eye for 4-year duration. IVTA was administered in his right eye for clinically significant macular edema (CSME) 2 months back. On examination, his best-corrected visual acuity (BCVA) in the right eye was 6/18, N6, and in the left eye was counting fingers at 2 m. Slit-lamp examination of his right eye revealed pseudophakia with minimal anterior chamber reaction. Intraocular pressure (IOP) of the right eye, measured with applanation tonometry, was 27 mmHg. Anterior segment examination of the left eye was within normal limits including a normal IOP. Fundus examination of the right eye revealed a large area of retinitis inferior to the disc with few hemorrhages [Fig. 1]. Left eye posterior segment examination revealed optic atrophy. Optical coherence tomography revealed an epiretinal membrane (ERM) and retinal thickening inferonasal to fovea with shallow subretinal fluid [Fig. 2]. A provisional diagnosis of atypical necrotizing retinitis due to infectious etiology was considered. Routine blood investigations were normal and he tested negative for human immunodeficiency virus 1 and 2. Polymerase chain reaction (PCR) of aqueous aspirate from his right eye was positive for Toxoplasma gondii genome with the sequence (B1-5'TCT TTA AAG CGT TCG TGG TC 3') and negative for herpes simplex, varicella zoster, and cytomegalovirus genomes. Enzyme-linked immunosorbent assay (ELISA) test in serum for antibodies to T. gondii was also positive for IgG antibodies (410 IU/ml). A diagnosis of necrotizing retinitis due to toxoplasma in the right eye was made, and the patient was started on a multidrug regimen of oral clindamycin 300 mg four times per day and combination of sulfamethoxazole and trimethoprim (double strength, 800 mg sulfamethoxazole and 160 mg trimethoprim) twice per day. Oral steroids at a dose of 1 mg/kg/day were initiated 2 days after initiating anti-toxoplasma treatment. Serial follow-up at 4 weeks showed a regressing lesion [Fig. 3]. The retinitis had completely resolved 3 months after initiation of treatment. At final follow-up, 20-month postfirst visit, the patients’ BCVA was 6/12, N6, and no recurrences have been noted till date. Figure 1 Montage fundus photograph of the right eye showing a large, whitish, fluffy lesion inferior to the disc and inferonasal quadrant. A clump of residual intravitreal triamcinolone acetonide is seen in the inferior vitreous Figure 2 Optical coherence tomography showed a posterior vitreous detachment along with an epiretinal membrane. Foveal contour is noted with retinal thickening and subretinal fluid inferonasal to the fovea Figure 3 Serial monitoring of the lesion shows progressive resolution. (a) At presentation. (b) At 1 month. (c) Three months after presentation Discussion There have been anecdotal reports of fulminant toxoplasma retinochoroiditis following systemic and depot corticosteroid administration.[111213] Furthermore, there are few reports of using intravitreal corticosteroid as adjunct in the management of severe cases of toxoplasma retinochoroiditis.[1415] Toxoplasmic retinochoroiditis can present in atypical forms, especially in immunocompromised state. Elderly patients can be at risk of more severe involvement due to waning immune system.[34] In our patient, advanced age and the uncontrolled glycemic status could have led to an immunocompromised state. In a report by Takakura et al.,[16] 12 of the 30 patients, who developed viral retinitis following intraocular or periocular steroid injection, were diabetics and the authors postulated that the diabetic vasculopathy facilitated the entry of the microorganism into the retina leading to the development of retinitis. Four cases of toxoplasma retinochoroiditis following intravitreal injection of corticosteroid have been reported in literature [Table 1].[3917] Olson et al. reported a case of toxoplasma retinochoroiditis in a 74-year-old male, who was treated with intravitreal dexamethasone for iridocyclitis and vitritis refractory to topical difluprednate. The patient developed severe anterior chamber inflammation with raised IOP and fundus examination revealed vitritis, retinal vasculitis, and retinitis. As was seen in our patient, majority of the cases reported in literature presented with retinitis following intravitreal injection of corticosteroid and was initially diagnosed as viral retinitis. Table 1 Review of literature of cases of ocular toxoplasmosis following intravitreal corticosteroid Toxoplasmic retinochoroiditis may mimic viral retinitis early phase of ocular involvement because of its predominant retinal involvement, which subsequently involves choroid to manifest as retinochoroiditis.[18] PCR testing of intraocular fluids and ELISA for anti-toxoplasma antibodies can help establish the diagnosis in atypical presentations as was seen in our patient. Treatment with multidrug regimen of anti-toxoplasma therapy along with tight diabetic control helped resolution of inflammation and restoration of vision. Intravitreal corticosteroids, due to their immunosuppressive actions, suppress host immunity and may lead to release of T. gondii from intraretinal cyst resulting in ocular disease with enormous tissue destruction. IVTA which was given in our patient for the management of CSME probably led to local immunosuppression and subsequent development of de novo toxoplasma retinitis as he had no evidence of old toxoplasmic scars which could indicate reactivation of latent disease. Rush and Seth[9] described two cases of fulminant toxoplasmic retinochoroiditis and exerted a caution on treating conditions such as panuveitis with intravitreal corticosteroid, particularly in population with higher prevalence of toxoplasmosis. Nóbrega and Rosa[3] reported a case of reactivation of a toxoplasma satellite lesion in a 84-year-old-male which had developed adjacent to an atrophic scar post-IVTA and photodynamic therapy for presumed choroidal neovascular membrane secondary to age-related macular degeneration. Conclusion This case report and review of literature aims to elevate awareness of the possibility of the rare occurrence of toxoplasma retinochoroiditis in patients receiving intravitreal corticosteroid. It is important to have proper glycemic control when planning IVTA. Clinicians need to carefully monitor the patients following administration of intravitreal medication and diagnosis of toxoplasma retinochoroiditis should be kept in mind while dealing with retinitis mimicking viral retinitis. Proper microbiological diagnosis aided by the use of newer laboratory investigations such as real-time PCR, and rapid, effective, and appropriate antimicrobial therapy can prevent devastating complications in infectious posterior uveitic diseases in such cases. Declaration of patient consent The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed. Financial support and sponsorship Nil. Conflicts of interest There are no conflicts of interest. ==== Refs 1 Han JM Ahn J Park KH Woo SJ Presumed necrotizing viral retinitis after intravitreal triamcinolone injection: Case report Korean J Ophthalmol 2011 25 451 4 22131785 2 Mushtaq B Gupta R Elsherbiny S Murray PI Ocular syphilis unmasked following intravitreal triamcinolone injection Ocul Immunol Inflamm 2009 17 213 5 19585366 3 Nóbrega MJ Rosa EL Toxoplasmosis retinochoroiditis after photodynamic therapy and intravitreal triamcinolone for a supposed choroidal neovascularization: A case report Arq Bras Oftalmol 2007 70 157 60 17505739 4 Park YS Byeon SH Cytomegalovirus retinitis after intravitreous triamcinolone injection in a patient with central retinal vein occlusion Korean J Ophthalmol 2008 22 143 4 18612235 5 Saidel MA Berreen J Margolis TP Cytomegalovirus retinitis after intravitreous triamcinolone in an immunocompetent patient Am J Ophthalmol 2005 140 1141 3 16376669 6 Toh T Borthwick JH Acute retinal necrosis post intravitreal injection of triamcinolone acetonide Clin Exp Ophthalmol 2006 34 380 2 16764663 7 Tugal-Tutkun I Araz B Cagatay A CMV retinitis after intravitreal triamcinolone acetonide injection in a patient with Behçet's uveitis Int Ophthalmol 2010 30 591 3 20033756 8 Song JH Hong YT Kwon OW Acute syphilitic posterior placoid chorioretinitis following intravitreal triamcinolone acetonide injection Graefes Arch Clin Exp Ophthalmol 2008 246 1775 8 18751717 9 Rush R Sheth S Fulminant toxoplasmic retinochoroiditis following intravitreal triamcinolone administration Indian J Ophthalmol 2012 60 141 3 22446913 10 Fardeau C Romand S Rao NA Cassoux N Bettembourg O Thulliez P Diagnosis of toxoplasmic retinochoroiditis with atypical clinical features Am J Ophthalmol 2002 134 196 203 12140026 11 Sabates R Pruett RC Brockhurst RJ Fulminant ocular toxoplasmosis Am J Ophthalmol 1981 92 497 503 7294112 12 O'Connor GR Frenkel JK Editorial: Dangers of steroid treatment in toxoplasmosis. Periocular injections and systemic therapy Arch Ophthalmol 1976 94 213 1252171 13 Bosch-Driessen LE Berendschot TT Ongkosuwito JV Rothova A Ocular toxoplasmosis: Clinical features and prognosis of 154 patients Ophthalmology 2002 109 869 78 11986090 14 Aggio FB Muccioli C Belfort R Jr Intravitreal triamcinolone acetonide as an adjunct in the treatment of severe ocular toxoplasmosis Eye (Lond) 2006 20 1080 2 15 Backhouse O Bhan KJ Bishop F Intravitreal triamcinolone acetonide as an adjunct in the treatment of severe ocular toxoplasmosis Eye (Lond) 2008 22 1201 2 18259204 16 Takakura A Tessler HH Goldstein DA Guex-Crosier Y Chan CC Brown DM Viral retinitis following intraocular or periocular corticosteroid administration: A case series and comprehensive review of the literature Ocul Immunol Inflamm 2014 22 175 82 24655372 17 Olson DJ Parhiz AT Wirthlin RS Reactivation of latent toxoplasmosis following dexamethasone implant injection Ophthalmic Surg Lasers Imaging Retina 2016 47 1050 2 27842200 18 Moshfeghi DM Dodds EM Couto CA Santos CI Nicholson DH Lowder CY Diagnostic approaches to severe, atypical toxoplasmosis mimicking acute retinal necrosis Ophthalmology 2004 111 716 25 15051204